Avery Biomedical Devices Revenue
Medical Equipment Manufacturing • 
Commack, New York, United States • 21-50 Employees
Avery Biomedical Devices revenue & valuation
| Annual revenue | $14,400,000 |
| Revenue per employee | $655,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $46,100,000 |
| Total funding | No funding |
Key Contacts at Avery Biomedical Devices
Fahad Shah
Director Quality And Regulatory Affairs
Linda Towler
Chief Executive Officer
Company overview
| Headquarters | 61 Mall Dr, Commack, NY 11725, US |
| Phone number | +16318641600 |
| Website | |
| NAICS | 3391 |
| SIC | 384 |
| Keywords | Robotic, ICU, Trauma, Respiratory Therapy, Thoracic Surgery, Neurosurgery, Pediatric Surgery, Spinal Cord Injury, Pediatric, Pulmonary, Sleep Medicine, MVA, Polysomnography, SCI, Cervical Surgery, Adults And Children, Diaphragm, Pm&R, NPV, Central Sleep Apnea, PNS, Quadriplegia, Central Hypoventilation Syndrome (Chs), Diaphragm Pacemaker, Phrenic Nerve Stimulator, Vats, Tetraplegia, Pediatric Pulmonary, Diaphragm Pacing, Chronic Respiratory Insufficiency, Decanulation, Natural Breathing, Negative Pressure Breathing, Phrenic Pacing, Phrenic Stimulator, Rohhad, Diaphragmatic Pacing |
| Founded | 1970 |
| Employees | 21-50 |
| Socials |
Avery Biomedical Devices Email Formats
Avery Biomedical Devices uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@averybiomedical.com), used 61.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@averybiomedical.com | 61.1% |
{first initial}.{last name} | j.doe@averybiomedical.com | 33.3% |
{first initial} | j@averybiomedical.com | 5.6% |
About Avery Biomedical Devices
At Avery Biomedical Devices, we are dedicated to improving the lives of ventilator-dependent patients through the Avery Diaphragm Pacemaker—a clinically proven, cost-effective alternative to mechanical ventilation that promotes natural breathing. The Avery Diaphragm Pacemaker (phrenic nerve stimulator) is indicated for adult and pediatric patients who require chronic ventilatory support due to upper motor neuron respiratory muscle paralysis (RMP) or central alveolar hypoventilation (CAH)—including conditions such as Congenital Central Hypoventilation Syndrome (CCHS)—and whose remaining phrenic nerve, lung, and diaphragm function is sufficient to accommodate electrical stimulation. Typically, these patients have high spinal cord injuries, central hypoventilation, central sleep apnea, or a paralyzed diaphragm of various etiologies, including brainstem lesions or chronic pulmonary disease with ventilatory insufficiency. By stimulating the phrenic nerve, the Avery system enables natural, rhythmic breathing without the need for traditional mechanical ventilation. It offers patients greater mobility, lower infection risk, long-term reliability, and a higher quality of life—all while reducing the cost of care.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Avery Biomedical Devices has 12 employees across 4 departments.
Departments
Number of employees
Funding Data
Avery Biomedical Devices has never raised funding before.
Italy
Spain
Poland
United Arab Emirates
BrazilFrequently asked questions
4.8
40,000 users
